Vertex Pharmaceuticals Incorporated (0QZU.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 116.43B |
| Enterprise Value | 115.22B |
| P/E Ratio | 31.64 |
| PEG Ratio | 1.41 |
| Price/Sales Ratio | 11.02 |
| Price/Book Ratio | 6.87 |
| Enterprise/Revenue | 10.69 |
| Enterprise/EBITDA | 24.78 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.35 |
| Operating Margin | 0.39 |
AD
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.23 |
Income Statement
| Revenue | 12.07B |
| Revenue/Share | 49.72 |
| Gross Profit | 10.27B |
| EBITDA | 4.97B |
| Net Income | 3.95B |
| Diluted EPS | 15.32 |
Balance Sheet
| Total Cash | 7.85B |
| Total Cash/Share | 30.93 |
| Total Debt | 1.98B |
| Total Debt/Equity | 0.1 |
| Current Ratio | 3.19 |
| Book Value Per Share | 79.75 |
Price History
| 52-Week Change | 37.12 |
| 52-Week High | 560 |
| 52-Week Low | 290.87 |
| Moving Average 50 Days | 424.38 |
| Moving Average 200 Days | 373.25 |
Statistics
| Average Volume | 2,907 |
| Shares Outstanding | 255.56M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
